09.02.2014 Views

COSIG CONFERENCE BROCHURE.pdf - Drexel University College ...

COSIG CONFERENCE BROCHURE.pdf - Drexel University College ...

COSIG CONFERENCE BROCHURE.pdf - Drexel University College ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>COSIG</strong> Co-Occurring Disorders Conference, Hershey PA, May 15-17, 2006<br />

Medication Use with Co-Occurring<br />

Disorders (The Why and Why Not of<br />

Prescribing Medications)<br />

The Real Goal<br />

• “The challenge for clinicians lies in<br />

matching a patient’s clinical and<br />

biochemical profile with that of a<br />

drug’s pharmacological actions, in<br />

order to achieve optimum outcomes”<br />

Craig Strickland, Ph.D.<br />

Voruganti, Cortese and Oweumi, et. al.<br />

(2002)<br />

Mindset:<br />

Risk factors influencing both psychiatric<br />

and D&A disorders<br />

• Genetic Risk<br />

–Structural changes<br />

–Neurochemical changes<br />

• Environmental risk: socioeconomic<br />

and some of the more “external” factors<br />

• Pharmacological risk: this category<br />

truly refers to the why and the why<br />

not of prescribing medications<br />

Mindset:<br />

What are the goals of<br />

Psychopharmacology???<br />

•Reduction of psychiatric and D&A<br />

symptoms in terms of:<br />

–Symptom Intensity<br />

–Symptom Frequency<br />

–Symptom Duration<br />

• Minimize Side-effects<br />

Mindset:<br />

“Side-effects”of medications<br />

can cause:<br />

• Physical side-effects (including<br />

tolerance and withdrawal)<br />

• Stimulating, sedating or euphorigenic<br />

effects<br />

•Abuse and/or addiction potential<br />

• D&A disorder relapse<br />

• Psychiatric disorder relapse<br />

TREATING<br />

SCHIZOPHRENIA<br />

1

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!